checkAd

    Wurde Visualmed bisher übersehen? - 500 Beiträge pro Seite

    eröffnet am 04.08.05 11:16:31 von
    neuester Beitrag 29.08.05 18:16:52 von
    Beiträge: 5
    ID: 997.781
    Aufrufe heute: 0
    Gesamt: 1.549
    Aktive User: 0

    Werte aus der Branche Gesundheitswesen

    WertpapierKursPerf. %
    0,7400+36,63
    6,6300+26,05
    16,120+25,35
    27,00+22,84
    44,72+22,32
    WertpapierKursPerf. %
    1,2000-14,29
    18,210-25,70
    2,4100-51,51
    2,0400-56,69
    3,3900-84,64

     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 04.08.05 11:16:31
      Beitrag Nr. 1 ()
      Ich möchte mal wissen was hier die Fachleute zu dieser Aktie sagen?:confused:
      Der Chart sieht ja ganz anstendig aus:D
      Avatar
      schrieb am 04.08.05 14:37:40
      Beitrag Nr. 2 ()
      letzte Meldung vom 13 Juni 05

      VisualMED Clinical Solutions Corp.: Business Leaders and Dean of Medical School Join Advisory Board
      MONTREAL, Jun 13, 2005 (BUSINESS WIRE) -- VisualMED Clinical Solutions Corp. (OTCBB: VMCS) announces today the appointments of three new members to serve on its Board of Advisors. The Board is made up of independent business and professional leaders who assist the company in developing and implementing corporate policy. The Board plays a particularly important role in formulating sales and marketing strategies, product financing models for client hospitals as well as understanding the political context of Healthcare.

      Mr. Andre Nadeau, a mergers and acquisitions specialist with years of information technology experience, will chair the committee. Mr. Nadeau has worked in the information technology field for more than 15 years, most notably as chief strategy officer for CGI one of America`s largest integration companies with close to 4 billion in sales. His knowledge and experience should help the company pursue more alliances with value added resellers in Europe and America.

      Also joining is Mr. Christian Chagnon, co-founder and Managing Partner at I-U-GO Ventures Inc., one of Canada`s largest private equity funds focused on Information technology companies. Mr. Chagnon was Senior Vice President, Strategic Planning and Technology at Montreal-based Group Videotron Ltd., which was sold in 2000 for 5,4 billion. Mr. Chagnon is a board member of various private companies and of a Montreal-based Hospital Foundation.

      Dr. Jean Rouleau, Dean of the University of Montreal`s Faculty of Medicine will also be joining the Board. An outspoken supporter of healthcare reform Dean Rouleau will help the company focus on public sector priorities in its dealings with government and healthcare authorities.

      The Advisory Board will help the Company create better marketing strategy, and help tailor VisualMED`s sales approach to the evolving realities of a complex marketplace. One of its main efforts will be to find concrete ways of bringing public attention to VisualMED`s success at a time when the United States Senate is about to table a multi-billion dollar appropriation to help American hospitals pay for CPOE and other technologies that support electronic health record and clinical decision support.

      This rare bi-partisan initiative on Capitol Hill, is distinctly positive for our industry, especially considering that the bill is being sponsored by Republican Majority Leader Bill Frisk as well as by Democrats such as Senator Hilary Rodham Clinton. Congressional unity would encourage the wide-scale acquisition of cutting edge technology such as The VisualMED flagship Clinical Information System that has been in continuous operation at Physicians Hospital of El Paso, in the President`s home state of Texas.

      About the Company and its products

      VisualMED Clinical Solutions Corp. is a leading provider of clinical informatics solutions that help hospitals and healthcare authorities reduce medication errors, increase personnel efficiency and bring down operating costs. One of its key components, Computerized Physician Order Entry (CPOE), is a core solution in the new agenda to promote greater patient safety and reduce the morbidity and mortality associated with medication error. The company is involved in major government initiatives on three continents to modernize hospitals and healthcare delivery.

      Forward-Looking Statements

      Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management`s best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company`s products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

      SOURCE: VISUALMED CLINICAL SOLUTIONS CORP.

      CONTACT: VisualMED Clinical Solutions Corp.
      Barry Scharf, COO, 514-274-1115, Ext.108
      Website: www.visualmedsolutions.com

      Copyright Business Wire 2005
      Avatar
      schrieb am 04.08.05 15:58:59
      Beitrag Nr. 3 ()
      Avatar
      schrieb am 15.08.05 17:20:53
      Beitrag Nr. 4 ()
      :look: langsam steigt auch der Umsatz! Die ersten scheinen es endlich auch zu bemerken, dass hier was abgehen wird!! :cool::lick::D
      Avatar
      schrieb am 29.08.05 18:16:52
      Beitrag Nr. 5 ()
      hallo :D

      hab mir auch welche zugelegt glaube die story hat future.

      news sind noch rar.

      visualmed in musterdepot aufgenommen:

      http://www.aktienboard.com/vb/musterdepot.php?do=show&year=2…

      mfg amun


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.

      Investoren beobachten auch:

      WertpapierPerf. %
      +0,20
      +0,76
      +1,99
      +1,69
      -9,09
      0,00
      -0,53
      +1,17
      -1,07
      0,00

      Meistdiskutiert

      WertpapierBeiträge
      237
      90
      76
      67
      52
      48
      37
      35
      32
      31
      Wurde Visualmed bisher übersehen?